Trials / Completed
CompletedNCT00159900
Quality of Erection Study
A Multicenter, Parallel Group Flexible Dose Study With A Double Blind, Randomized, Placebo Controlled Phase And An Open-Label Phase To Evaluate The Quality Of Erections In Men With Erectile Dysfunction Treated With Sildenafil Citrate
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to evaluate the effect that sildenafil citrate has on the hardness of erections in males with erectile dysfunction, based on subject responses to question 5 on the Event Log (hardness of erection) as measured at the end of double blind treatment (week 6).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil Citrate |
Timeline
- Start date
- 2005-05-01
- Completion
- 2006-01-01
- First posted
- 2005-09-12
- Last updated
- 2021-02-01
Locations
23 sites across 5 countries: Brazil, Germany, Italy, Poland, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00159900. Inclusion in this directory is not an endorsement.